HIKMA PHARMACEUTICALS USA INC.
Sign in to add to a watchlist →
lobbying_client · US · canonical: hikma pharmaceuticals usa inc. · 1 alias · 0 outbound · 3 inbound
Related entities (24)
Same brand-name cluster — possible parent, subsidiary, PAC, or lobbying registration. Surfaced via head-token match (e.g. every "AMAZON …" org) and pg_trgm similarity for variant spellings. Not yet asserted as parent/child edges; treat as a navigation aid.
- TEVA PHARMACEUTICALS USA INC. POLITICAL ACTION COMMITTEE (TEVA PAC)pac · trigram 0.65
- TEVA PHARMACEUTICALS USAlobbying_client · trigram 0.65
- TEVA PHARMACEUTICALS USA, INC.corporation · trigram 0.57
- TEVA PHARMACEUTICALS USA INClobbying_client · trigram 0.57
- TEVA PHARMACEUTICALS USA, INC.lobbying_client · trigram 0.57
- TEVA PHARMACEUTICALS USA, INC.lobbying_firm · trigram 0.57
- TELIX PHARMACEUTICALS USlobbying_client · trigram 0.55
- CMC PHARMACEUTICALSlobbying_client · trigram 0.53
- NRX PHARMACEUTICALSlobbying_client · trigram 0.53
- Jazz Pharmaceuticals plccorporation · trigram 0.52
- JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEEpac · trigram 0.52
- KING PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEEpac · trigram 0.52
- JAZZ PHARMACEUTICALSlobbying_client · trigram 0.52
- PHATHOM PHARMACEUTICALSlobbying_client · trigram 0.52
- APCO WORLDWIDE LLC (ON BEHALF OF HIKMA PHARMACEUTICALS USA INC.)lobbying_client · trigram 0.51
- AGIOS PHARMACEUTICALS, INC.corporation · trigram 0.50
- MYLAN PHARMACEUTICALS INC POLITICAL ACTION COMMITTEEpac · trigram 0.50
- SHIRE PHARMACEUTICALS INC POLITICAL ACTION COMMITTEEpac · trigram 0.50
- AGIOS PHARMACEUTICALSlobbying_client · trigram 0.50
- ALORA PHARMACEUTICALS, LLClobbying_client · trigram 0.50
- IONIS PHARMACEUTICALS, INC.lobbying_client · trigram 0.50
- LUPIN PHARMACEUTICALS INC.lobbying_client · trigram 0.50
- PACIRA PHARMACEUTICALS INC.lobbying_client · trigram 0.50
- RECCE PHARMACEUTICALSlobbying_client · trigram 0.50
Timeline
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; the inline strip under the row shows the counterpart's own context (a bill's latest action, a hearing's chamber + date, a filing's form type + filed date, a clip's source + excerpt) so the timeline reads like a Wikipedia citation rail.
- 2026-05-23 · lobbied by Dan Scandling · lda_lobbyist_client
- 2026-05-23 · lobbied by Allison Parker-Lagoo · lda_lobbyist_client
- 2026-05-23 · lobbied by Mikasa Modi · lda_lobbyist_client
Lobbying disclosures — as CLIENT (1)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-20 | 1st Quarter - Report | 2026 | first_quarter | 4117 | $30,000 | — |
Connected on the graph
3 typed relationships in the influence graph — 3 inbound, 0 outbound, grouped by type.
lobbied for (3)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Dan Scandling | — | lda_lobbyist_client | |
| — | ← | Allison Parker-Lagoo | — | lda_lobbyist_client | |
| — | ← | Mikasa Modi | — | lda_lobbyist_client |
Aliases (1)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 213697 | HIKMA PHARMACEUTICALS USA INC. | US | gold | sync_canonical_entities |